Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLECAPRO: Flecainide and Metoprolol vs Metoprolol Alone in Arrhythmic Mitral Valve Prolapse
NCT05631730Phase 3Active, not recruiting
- Sponsor
- Oslo University Hospital
- Start
- Jan 2023
- Primary completion
- Aug 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of flecainide in ventricular arrhythmia (VA), mitral valve prolapse (MVP), sponsored by Oslo University Hospital. Started Jan 2023; status: active, not recruiting.
02
Drugs
flecainide
03
Conditions
ventricular arrhythmia (VA)mitral valve prolapse (MVP)
Beyond the preview
Go deeper on NCT05631730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05631730.